
ExSeed Health
MedTech / Software company in the reproductive health space.
Related Content
ExSeed Health, founded in 2017 by Morten G. Ulsted, Emil Andersen, Daniel Daugaard-Jensen, and Torben Ulsted, is a health technology company addressing male infertility. The company is headquartered in London, with a team also in Copenhagen. The founders' backgrounds are rooted in science and business. CEO Morten G. Ulsted has a background in economics, business administration, and project management, including roles at Novo Nordisk. Chief Scientific Officer Emil Andersen holds a Ph.D. in Human Reproduction and Epigenetics from the University of Copenhagen and was inspired to start the company by his interest in how environment and behavior impact fertility, as well as his own personal experiences. Daniel Daugaard-Jensen has a background in business and has also worked at Novo Nordisk.
ExSeed Health operates in the male fertility market, targeting a segment it identifies as historically neglected, given that male-related factors contribute to approximately 40% of infertility cases. The company's business model encompasses both direct-to-consumer (D2C) sales through its website and business-to-business (B2B) channels, partnering with fertility clinics and other corporate customers. Revenue is generated from the sale of its testing kits, refill kits, and fertility supplements. The company has secured over $6.8 million in funding across several seed rounds from investors including Ascension, Trifork, and Salica Investments.
The company's core product is an at-home sperm testing kit that is CE-certified as an in-vitro diagnostics medical device. The kit includes a smartphone-compatible analysis device that uses micro-optic technology and an AI-powered algorithm to analyze a sperm sample. Within minutes, users can view a live video of their sperm and receive results on key metrics such as sperm volume, concentration, motility, and total motile sperm count, which are benchmarked against World Health Organization standards. This analysis claims an accuracy of over 95% when compared to traditional laboratory equipment. Beyond diagnostics, the accompanying mobile app provides users with a personalized lifestyle program based on their results and health data, offering guidance on nutrition and behavior to help improve sperm quality. The platform also offers access to fertility specialists for consultations.
Keywords: male fertility, sperm testing, at-home diagnostics, health technology, reproductive health, fertility solutions, sperm analysis, medtech, digital health, direct-to-consumer healthcare, fertility supplements, lifestyle intervention, sperm count, sperm motility, CE certified medical device, telehealth, reproductive medicine, fertility coaching, semen analysis, personalized health